These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7143155)

  • 21. Failure of acute saralasin to reverse chronic hypertension in fetal lambs.
    Anderson DF; Binder ND
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R811-6. PubMed ID: 2012252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Variable action of central and peripheral angiotensin II blockade in genetic hypertension in rats].
    Mann JF; Phillips MI; Dietz R; Haebara H; Lüth JB; Ganten D
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():189-90. PubMed ID: 613564
    [No Abstract]   [Full Text] [Related]  

  • 23. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saralasin infusion in screening patients for renovascular hypertension.
    Krakoff LR; Ribeiro AB; Gorkin JU; Felton KR
    Am J Cardiol; 1980 Mar; 45(3):609-13. PubMed ID: 6986750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG; Parker FB; Poirier RA; Anderson G; Streeten DH; Blackman M
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension].
    Beckerhoff R; Vetter W; Furrer J; Tuma J; Zàruba K; Vetter H; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1738-41. PubMed ID: 1013696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Saralasin in resistant hypertensive crisis (author's transl)].
    Röckel A; Heidland A
    Med Klin; 1979 Mar; 74(11):401-7. PubMed ID: 34782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saralasin infusion in renovascular hypertension: increased response rate in seated patients.
    Tucker RM; Sheps SG; Brennan LA
    Mayo Clin Proc; 1980 Feb; 55(2):99-102. PubMed ID: 7354651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe hypotension before saralasin infusion.
    Naik RB; Wilson CA; Warren DJ
    Lancet; 1979 Jul; 2(8132):50-1. PubMed ID: 87935
    [No Abstract]   [Full Text] [Related]  

  • 34. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB; Laragh JH
    Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment].
    Cappelli G; Vagge R; Lamperi S
    Minerva Nefrol; 1979; 26(1):5-8. PubMed ID: 471322
    [No Abstract]   [Full Text] [Related]  

  • 36. Lowering of hypertension by central saralasin in the absence of plasma renin.
    Phillips MI; Mann JF; Haebara H; Hoffman WE; Dietz R; Schelling P; Ganten D
    Nature; 1977 Dec; 270(5636):445-7. PubMed ID: 593364
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement in arterial oxygenation by saralasin infusion in man.
    Mookherjee S; Obeid AI; Ashutosh K; Warner RA; Smulyan H
    Chest; 1979 Apr; 75(4):492-4. PubMed ID: 36260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic correlates of saralasin-induced arterial pressure changes.
    de Carvalho JG; Dunn FG; Kem DC; Chrysant SG; Froholich ED
    Circulation; 1978 Feb; 57(2):373-8. PubMed ID: 618629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
    Brod J; Bahlmann J; Cachovan M; Hubrich W; Pretschner D
    Nephron; 1980; 25(4):167-72. PubMed ID: 6990284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.